Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma Of Esophagus

Explore clinical trials studying Adenocarcinoma Of Esophagus. Study availability and eligibility vary by location and protocol.

254 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma Of Esophagus trial results

Completed

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

NCT03365791

Conditions
Adenocarcinoma Of Esophagus, Advanced Well-differentiated Neuroendocrine Tumors, Bronchial Neoplasms, +28 more
Locations
  • California Pacific Medical Center Drug Shipment (2) San Francisco, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Northwestern University Medical School Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

NCT00101972

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +80 more
Locations
  • Premiere Oncology Santa Monica, California, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

NCT00381706

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations
  • Norwalk Hospital Norwalk, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 227 locations
View Trial Details

Related conditions